Anti-inflammatory use during surgery could improve cancer outcomes

(RCSI) The world's first clinical trial (SURGUVANT) evaluating anti-inflammatory use at the time of surgery in colon cancer patients to improve their cancer outcome has been published in scientific journal, BMC Cancer.